Japan's Fujisawa Pharmaceutical Co. Ltd. said  Monday its pre-tax earnings dived 12 percent from a year earlier to 19.9  billion yen (193 million dollars) in the year to March.
The company, one of the country's biggest drugmakers and a leading force  in antibiotics, said sales were flat at 235 billion yen.
Fujisawa forecast lower earnings of 18 billion yen for the current year on  decreased sales of 227 billion yen.
